Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C

被引:68
作者
Cheung, RY
Ying, YM
Rauth, AM
Marcon, N
Wu, XY
机构
[1] Univ Toronto, Fac Pharm, Toronto, ON M5S 2S2, Canada
[2] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
[3] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
关键词
biodegradable MS; dextran derivatives; drug loading and release; kinetics and mechanism; cytotoxicity;
D O I
10.1016/j.biomaterials.2005.01.050
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The purpose of this work was to develop a biodegradable microsphere (MS) system for delivering mitomycin C (MMC). Various dextran-based MS systems were investigated for their loading and release characteristics, including nonionic MS, sulfopropyl dextran microspheres (SP-MS) with low or high cross-linking density, oxidized SP-MS (Ox-MS), and hydrophobically modified SP-MS. SP-MS were chemically modified by oxidation with sodium periodate or by reaction with anhydride. The chemical structure of modified SP-MS and MMC-loaded MS (MMC-MS) were examined using Fourier transform infrared (FTIR) and solid-state nuclear magnetic resonance (NMR) spectrophotometry. Drug release was conducted at 37 degrees C in aqueous solutions of 0.15 m phosphate buffer solution. The kinetics of drug absorption and release and the stability of MMC after loading and release were determined by spectrophotometry and high-performance liquid chromatography. Ionic SP-MS exhibited a higher drug-loading rate and capacity when compared to nonionic MS, while hydrophobically modified SP-MS showed an even greater loading capacity than SP-MS. These results suggest that both ionic complexation and hydrophobic interaction were important factors in MMC loading. The Ox-MS system demonstrated higher drug-loading capacity, more fractional drug release and a longer time to reach release equilibrium as compared to other investigated MS systems. Under optimized reaction and loading conditions, MMC released from Ox-MS was found to be unaltered. This work demonstrates that the Ox-MS system is a potentially useful system for the delivery of MMC. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5375 / 5385
页数:11
相关论文
共 31 条
[1]  
[Anonymous], ACTA PHARM TECHNOL
[2]   CHEMICAL MODIFICATION OF PULULAN .1. PERIODATE-OXIDATION [J].
BRUNEEL, D ;
SCHACHT, E .
POLYMER, 1993, 34 (12) :2628-2632
[3]   DEGRADATION KINETICS AND MECHANISM OF N-6-[(DIMETHYLAMINO)METHYLENE]MITOMYCIN-C IN AQUEOUS-SOLUTIONS [J].
CHEN, CM ;
COPPOLA, WP ;
JOHNS, WH ;
BOGARDUS, JB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (02) :208-210
[4]   A new approach to the in vivo and in vitro investigation of drug release from locoregionally delivered microspheres [J].
Cheung, RY ;
Kuba, R ;
Rauth, AM ;
Wu, XY .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :121-133
[5]  
CHEUNG RY, IN PRESS ANTICANCER
[6]  
CUMMINGS J, 1994, MICROSPHERES REGIONA, P141
[7]  
Davis S. S., 1984, MICROSPHERES DRUG TH
[8]   Injectable chemotherapeutic microspheres and glioma II: Enhanced survival following implantation into deep inoperable tumors [J].
Emerich, DF ;
Winn, SR ;
Snodgrass, P ;
LaFreniere, D ;
Agostino, M ;
Wiens, T ;
Xiong, H ;
Bartus, RT .
PHARMACEUTICAL RESEARCH, 2000, 17 (07) :776-781
[9]  
FISCHER DS, 1997, CANC CHEMOTHERAPY HD, P1
[10]   Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Fu, K ;
Pack, DW ;
Klibanov, AM ;
Langer, R .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :100-106